Volume 199 - Issue 9
Should we screen for lung cancer in Australia?
Authors: Mark Hew, Robert G Stirling and Michael J Abramson
Med J Aust 2013; 199 (9): 586. || doi: 10.5694/mja13.11158
Published online: 4 November 2013
Published online: 4 November 2013
In reply: We welcome the opportunity to respond to correspondence from Marshall and colleagues and Mitchell and colleagues about the impact of the National Lung Screening Trial (NLST)1 on three distinct issues: (i) current medical practice; (ii) developing public health policy; and (iii) implementation of future screening.
Current medical practice: We do
not currently recommend community screening. In the absence of resourced, educated, and coordinated referral ...
In reply: We welcome the opportunity to respond to correspondence from Marshall and colleagues and Mitchell and colleagues about the impact of the National Lung Screening Trial (NLST)1 on three distinct issues: (i) current medical practice; (ii) developing public health policy; and (iii) implementation of future screening.
Current medical practice: We do not currently recommend community screening. In the absence of resourced, educated, and coordinated referral and management pathways (which are essential to replicate successful NLST outcomes), we advise clinicians to focus on the available method of reducing lung cancer mortality — smoking cessation. For non-smokers, we urge doctors not to embark on ad-hoc screening outside appropriate frameworks, as this may harm patients.2
Public health policy: Whether coordinated screening should proceed depends on the final balance between numerous factors, including efficacy, affordability and equity. Screening efficacy continues to evolve,3 with refinements in selecting individuals at high risk, determining screening intervals, and managing screen-detected nodules. Cost-effectiveness and risk–benefit ratios will likely improve.
Formal cost-effectiveness data for screening are still pending.4 In the interim, we estimated the relative cost-effectiveness of screening and smoking cessation in our editorial.5 These figures favoured smoking cessation, so we emphasised the importance of intensified tobacco control. We are surprised that Mitchell and colleagues view this as therapeutic nihilism, as even the NLST authors argue: “cost-effectiveness of low-dose CT screening must also be considered in the context of competing interventions, particularly smoking cessation”.1
Screening offers greatest survival benefit to a high-risk group (comprising current and recent former heavy smokers) who develop early lung cancer.1 However, effective tobacco control and smoking cessation averts even more lung cancer deaths by preventing cancer in the first place.6 We should advocate just as strongly for this far larger (but future, and, as yet, anonymous) at-risk group, as we do for our immediate and identifiable high-risk group with early cancer.
Screening implementation: Our editorial indicated that results from the Queensland Lung Cancer Screening Study would be pivotal to guide the implementation of screening.5 Preliminary data from Marshall and colleagues are therefore timely and welcome. Decisions to implement screening beyond this pilot initiative should await publication of full results. We concur that integration of screening with national tobacco control and smoking cessation programs will be vital.
Competing interests
No relevant disclosures.
References
- National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365: 395-409. 0_CBBEJAHF
- Bach PB, Gould MK, Silvestri GA. Computed tomography screening for lung cancer. Ann Intern Med 2013; 159: 155-156. 0_i1142885
- Field JK, Oudkerk M, Pedersen JH, Duffy SW. Prospects for population screening and diagnosis of lung cancer. Lancet 2013; 382: 732-741. 0_i1142887
- Manser R, Lethaby A, Irving LB, et al. Screening for lung cancer. Cochrane Database Syst Rev 2013; (6): CD001991. 0_CBBBJCAG
- Hew M, Stirling RG, Abramson MJ. Should we screen for lung cancer in Australia [editorial]? Med J Aust 2013; 199: 82-83. 0_CBBGHGCG
- Moolgavkar SH, Holford TR, Levy DT, et al. Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975–2000. J Natl Cancer Inst 2012; 104: 541-548. 0_i1142895
Uneven Ground: Survival Differences Among Victorian Lung Cancer Patients by Location of Residence (2011–2023): A Retrospective Cohort Study
Evangeline Samuel, Eldho Paul, Mike Lloyd, Sanuki Tissera, Craig Underhill, Sagun Parakh, Phillip Parente, Inger Olesen, Javier Torres, Katharine See, Gavin M. Wright, David Langton, Thomas John, Matthew Conron, James Bartlett, Nicola Atkin, Nikolajs Zeps, Susan V. Harden, Wasek Faisal, John R. Zalcberg, Rob G. Stirling
Early-Onset Colorectal Cancer With Liver-Only Metastases: A Retrospective Cohort Study Integrating Prospectively Collected Real-World Clinical and Molecular Data From an Australian National Database (2009–2024) to Guide Treatment Planning
Savio G. Barreto, Christos S. Karapetis, Shahid Ullah, Matthew Burge, Susan Caird, Angus Campbell, Azim Jalali, Ross Jennens, Muhammad A. Khattak, Belinda Lee, Stephanie H. Lim, Shehara Mendis, Louise Nott, Timothy J. Price, Jeremy D. Shapiro, Jeanne Tie, Javier Torres, Colin Williams, Rachel Wong, Vanessa Wong, Peter Gibbs
Australian Pathways for Specialist Pain Management and Early Palliative Care for People With Pancreatic Cancer: Developed Using a Community Consensus Approach
Jennifer Philip, Melanie R. Lovell, Kylee Bellingham, Gail Garvey, Gregory B. Crawford, Nicole M. Rankin, Kara Burns, Isabel Young, Vivienne Milch, Dorothy Keefe, Katrina Anderson, James Lawson, Meinir Krishnasamy
Program Guidelines for the National Lung Cancer Screening Program: Targeted Lung Cancer Screening in High-Risk Individuals in Australia
Nicole M. Rankin, Rebecca Zosel, Lisa J. Whop, Raglan Maddox, Annette McWilliams, Miranda Siemienowicz, Jon Emery, Maria A. R. Lantin, Georgia Bartlett, Mikayla Wolfe, Abbey Diaz, Katrina Anderson, Lillian Liu, Cindy Toms, Sarah McDermott, Peter Bligh, Jeremy Chalke, Stephen Melsom, Claire E. Nightingale, Alison Brown, Sam Pope, Julia Brotherton, Anne Fidler, Michel Itel, Mark Brooke, Diane M. Pascoe, Fraser Brims, Tracy L. Leong, Emily Stone, Dorothy Keefe, Vivienne Milch
Beyond Mammography: Sovereignty and Relational Breast Care With Aboriginal and Torres Strait Islander Women
Devaleena Das, Jessica Gildersleeve, Amy Thomson, Aunty Gracelyn Smallwood, Lorelle Holland
Striving for Racial Equity in Oral Cancer Research: A Case Study
Sneha Sethi, Simon Naylor, Catherine Leane (Dharug/Gabrigal), Gail Garvey (Kamilaroi), Joanne Hedges (Yamatji), Lisa M. Jamieson, Nicolas Reid (Dharug/Gabrigal)